To hear about similar clinical trials, please enter your email below
Trial Title:
Patient Decision Aid for the Treatment of Actinic Keratosis
NCT ID:
NCT06008171
Condition:
Actinic Keratoses
Patient Decision Aid
Conditions: Official terms:
Keratosis, Actinic
Keratosis
Conditions: Keywords:
actinic keratosis
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Non-Randomized
Intervention model:
Parallel Assignment
Intervention model description:
Patients with an indication for treatment of field therapy for actinic keratosis will be
consulted with patient decision aid or without patient decision aid (conventional)
Primary purpose:
Other
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
Patient Decision Aid
Description:
A designed tool (by us) that help patients and providers talk and decide together about
field-directed treatment options for actinic keratosis.
Arm group label:
Patient Decision Aid
Summary:
This study evaluates whether a Patient Decision Aid for the field-directed treatment of
actinic keratosis has an effect on shared decision making and patient satisfaction.
Detailed description:
Actinic keratosis is the most common epithelial precancerous lesion among the Caucasian
race. With an increase in prevalence worldwide due to an aging population and rise of
ultraviolet exposure actinic keratosis are among the most frequently encountered skin
lesions in clinical practice.
There are many therapeutic modalities for the treatment of actinic keratosis, depending
on multiple factors such as distribution, characteristics, patient preference, side
effects, availability and costs. Treatment options can be divided into: lesion directed
therapy en field directed therapy.
A Patient Decision Aid for field-directed therapies for actinic keratosis may attribute
to better shared-decision making and patient satisfaction which on their part may
benefits treatment compliance and health outcomes and may lead to fewer disputes between
patients and doctors.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- diagnosis actinic keratosis in MaastrichtUMC+ or CatharinaHospital, Eindhoven
- age >18 years
Exclusion Criteria:
- no knowledge of Dutch language
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Ellen Oyen
Address:
City:
Maastricht
Country:
Netherlands
Status:
Recruiting
Contact:
Last name:
Ellen Oyen, drs
Phone:
+31(0)43-3877289
Email:
ellen.oyen@mumc.nl
Contact backup:
Last name:
Klara Mosterd, prof. dr.
Phone:
+31(0)43-3877289
Email:
k.mosterd@mumc.nl
Investigator:
Last name:
Ellen Oyen, drs
Email:
Sub-Investigator
Investigator:
Last name:
Klara Mosterd, prof. dr.
Email:
Principal Investigator
Start date:
November 1, 2022
Completion date:
December 2024
Lead sponsor:
Agency:
Maastricht University Medical Center
Agency class:
Other
Collaborator:
Agency:
Catharina Ziekenhuis Eindhoven
Agency class:
Other
Source:
Maastricht University Medical Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06008171
